Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 6001-6050 of 6051 result(s).
CYDY CytoDyn Inc
05/15/2019 7:32:59 PM
They need to release those videos i
CYDY CytoDyn Inc
05/15/2019 4:53:25 PM
Pleasantly surprised? If this raise
CYDY CytoDyn Inc
05/15/2019 1:06:05 PM
I bought more today and if it goes
CYDY CytoDyn Inc
05/14/2019 8:39:20 AM
We're getting $56 million dollars f
CYDY CytoDyn Inc
05/14/2019 7:24:26 AM
With 100,000 HIV patients suffering
CYDY CytoDyn Inc
05/14/2019 6:58:18 AM
With leronlimab's great safety prof
CYDY CytoDyn Inc
05/14/2019 5:41:04 AM
One of the things I looked at when
CYDY CytoDyn Inc
05/14/2019 4:58:12 AM
I can't imagine going from in vitro
CYDY CytoDyn Inc
05/11/2019 11:03:45 PM
Leronlimab should help your friend
CYDY CytoDyn Inc
05/11/2019 7:01:36 AM
I have a position in GALT. Phase 2
CYDY CytoDyn Inc
05/10/2019 8:31:39 PM
ICPT is the only one out with NASH
CYDY CytoDyn Inc
05/09/2019 9:09:56 AM
As long as the stock is not sold du
CYDY CytoDyn Inc
05/09/2019 7:02:17 AM
Maybe this is the pleasant surprise
CYDY CytoDyn Inc
05/09/2019 6:46:33 AM
In case anyone is confused about my
CYDY CytoDyn Inc
05/09/2019 12:21:40 AM
I'm quite surprised that overseas r
CYDY CytoDyn Inc
05/09/2019 12:01:26 AM
Worldwide sales 2018 for Xtandi are
CYDY CytoDyn Inc
05/08/2019 10:32:40 PM
Pure speculation but a superior pro
CYDY CytoDyn Inc
05/07/2019 4:29:57 PM
If I saw 50 patients most would wor
CYDY CytoDyn Inc
05/07/2019 3:30:16 PM
The moment I had access to DSL in 1
CYDY CytoDyn Inc
05/07/2019 2:54:53 PM
AOL no longer has any money for a s
CYDY CytoDyn Inc
05/06/2019 4:53:00 PM
Time of half life isn't dose depend
CYDY CytoDyn Inc
05/06/2019 10:50:27 AM
"Also, said they want to nail down
CYDY CytoDyn Inc
05/06/2019 10:09:10 AM
Quite funny Amateur's timeline went (1)
CYDY CytoDyn Inc
05/05/2019 6:35:24 AM
Only three reasons to keep hammerin
CYDY CytoDyn Inc
05/05/2019 1:00:59 AM
As things currently stand a reducti
CYDY CytoDyn Inc
05/04/2019 6:19:07 AM
It seems that virologic failure is
CYDY CytoDyn Inc
05/03/2019 5:43:03 PM
What preceded it was all about the
CYDY CytoDyn Inc
05/03/2019 9:02:49 AM
The big difference at least in mono
CYDY CytoDyn Inc
05/02/2019 10:26:14 PM
Is it true we have 50 million doses
CYDY CytoDyn Inc
05/02/2019 10:12:23 PM
Fast track doesn't automatically me
CYDY CytoDyn Inc
05/02/2019 9:59:45 PM
The 6 months referenced is for the
CYDY CytoDyn Inc
05/02/2019 9:43:18 PM
I had wondered whether they had req
CYDY CytoDyn Inc
05/02/2019 9:38:57 PM
With the increase in CD4 production
CYDY CytoDyn Inc
05/01/2019 11:38:20 PM
So in other words all small biophar
CYDY CytoDyn Inc
05/01/2019 1:08:26 PM
You have no idea what toxic financi
CYDY CytoDyn Inc
05/01/2019 10:37:08 AM
NP can't control what other entitie
CYDY CytoDyn Inc
05/01/2019 10:14:04 AM
Small raises are occurring so as to
CYDY CytoDyn Inc
04/30/2019 6:22:52 AM
The revolving door between governm
CYDY CytoDyn Inc
04/30/2019 2:30:04 AM
Sometimes why big companies prosper
CYDY CytoDyn Inc
04/30/2019 2:17:04 AM
I actually don't want to see a BO a
CYDY CytoDyn Inc
04/30/2019 2:12:37 AM
With the worth of Prostagene and hi
CYDY CytoDyn Inc
04/25/2019 7:47:28 PM
With high efficacy, very minor side
CYDY CytoDyn Inc
04/25/2019 7:19:08 PM
Short term price means nothing unle (1)
CYDY CytoDyn Inc
04/25/2019 7:17:39 PM
Are the MOD SQUADS at ihub global
CYDY CytoDyn Inc
04/24/2019 5:54:22 PM
Nader is trying to hammer out deals
CYDY CytoDyn Inc
04/19/2019 9:47:17 AM
7 patients in mono had an average
CYDY CytoDyn Inc
04/18/2019 11:13:18 PM
Looks like Pro-140 has superior sup
CYDY CytoDyn Inc
04/18/2019 8:59:14 PM
Leronlimab would seem to be superio
CYDY CytoDyn Inc
04/17/2019 1:05:43 PM
60 days was the original time frame
CYDY CytoDyn Inc
04/17/2019 12:58:19 PM
"CytoDyn currently has 45 patients
Go to page:
  • << First
  • < Previous
  • 120
  • 121
  • Next >

Recent Articles

  • Oculis Reveals Breakthrough Findings on Privosegtor Therapy
  • Danske Bank's Recent Share Buyback Activities Analyzed
  • Oculis Reveals Promising Phase 2 ACUITY Results at ECTRIMS
  • Understanding A.P. Møller - Mærsk's Recent Share Transactions
  • Treatt plc’s Recent Market Activities and Insights
  • Berkshire Hathaway Completes Exit from BYD After 17 Years
  • Stock Market Enthusiasm Rises as Dow Celebrates Milestone
  • Alm. Brand A/S Updates on Recent Share Buyback Activity
  • AFL's Credit Rating Update: Navigating Financial Challenges
  • Michael Saylor Discusses Bitcoin's Sideways Movement Factors
  • Investors Encouraged to Join Altimmune Class Action Suit
  • KENT&CURWEN Spring/Summer 2026 Collection Shines Bright
  • Xinjiang's Foreign Trade Achieves Remarkable Growth and Openness
  • Revolutionizing Women's Health with Urine-Based Screening
  • IUNIK's Beta-Glucan Serum: A Fresh Take on Hydration
  • Join the Fight: Lockheed Martin Investors May Seek Justice
  • Investors Take Action: Join Lineage, Inc. Fraud Investigation
  • Trace One Welcomes New CEO Séverine Tourpin with Vision
  • Myricx Bio Welcomes Mohit Rawat as New CEO to Lead Growth
  • Trump's New Investors in TikTok: A Look at American Icons
  • Snap Inc. Stock Surges Amid New Product Launch and Market Dynamics
  • Stocks to Monitor This Week: Insights on Market Trends
  • Hoymiles Launches Innovative Hi Series for Energy Independence
  • Apollo Athenaa: Transforming Cancer Care for Women in Asia
  • Project Namsan Redefines Stablecoin Transactions with SOOHO.IO
  • Trip.Biz Unveils Transformative Business Travel Platform
  • Jyske Bank's Ongoing Share Repurchase Initiatives Detailed
  • C4X Discovery Advances Innovative Candidate for IBD Treatment
  • Realkredit Danmark A/S Publishes Latest Prepayment Announcements
  • MediaTek Dimensity 9500: Revolutionizing Mobile Technology
  • Samsung and Nvidia Partnering: A New Era in AI Chip Technology
  • Truecaller B Shares Buyback Program Update for Week 38
  • Unveiling Supermicro's Cutting-Edge AI Systems for 2025 and Beyond
  • Celebrating Blubrry's Legacy: Todd Cochrane's Impact in Podcasting
  • Exploring MediaTek Dimensity 9500: Revolutionizing Mobile AI
  • Govee Redefines Outdoor Ambiance with New Prism Lighting
  • Akeso Advances Cancer Treatment with New Bifunctional Antibody
  • Golar LNG Limited Engages Investors for Upcoming Notes Offering
  • Ross Gerber Critiques Tesla's FSD After Infamous Road Trip
  • The Rise of Humanoid Robots: Challenges and Opportunities Ahead
  • Transforming Guest Engagement at Leading Expo Events
  • Transformative Trends in the Logic Integrated Circuit Market
  • Exploring the Future of A2A Payment Growth by 2030
  • Euronext Completes Share Repurchase Program to Boost Shareholder Confidence
  • Leading Edge Materials Advances Norra Kärr Heavy Rare Earth Elements Project
  • Nexans Secures €250 Million Funding for Sustainable Development
  • INVL Technology's Share Price Target Increased by Enlight Research
  • Foresight Group Holdings Reports Share Buyback Details
  • NBPE's Recent Class A Share Buy-Back Announced
  • Stelpe Solar Farm II Commences Operations with 72.5 MW Capacity
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site